LONDON: Asset managers in the UK may be facing more rules dictating how to classify environmental, social and governance (ESG) investments than their peers in the European Union, creating extra red tape for firms that do business in both jurisdictions.
The UK’s Financial Conduct Authority (FDA) released a consultation paper outlining an initial approach for how asset managers should label ESG products.
Already a subscriber? Log in
The Star Festive Promo: Get 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
